StonvexLoading…
StonvexStonvexStonvexCore line items from CATY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.55M | $53.79M | $39.94M | $25.39M |
Operating Income | $109.95M | $390.20M | $276.73M | $182.97M |
Net Income | $86.89M | $315.12M | $224.61M | $146.96M |
EPS (Diluted) | $1.29 | $4.54 | $3.21 | $2.09 |
Total Assets | $24.05B | $24.23B | $24.08B | $23.72B |
Total Liabilities | $21.06B | $21.30B | $21.17B | $20.84B |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $96.03M | $363.66M | $309.05M | $158.95M |
Shares Outstanding | 66.97M | 67.20M | 68.29M | 69.34M |